James Sidoti
Stock Analyst at Sidoti & Co.
(1.87)
# 1,740
Out of 4,553 analysts
7
Total ratings
66.67%
Success rate
60.05%
Average return
Main Sectors:
Stocks Rated by James Sidoti
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SRDX Surmodics | Downgrades: Neutral | $43 | $38.83 | +10.74% | 1 | May 29, 2024 | |
| STAA STAAR Surgical Company | Upgrades: Buy | n/a | $31.12 | - | 2 | Nov 7, 2022 | |
| CODX Co-Diagnostics | Downgrades: Neutral | $5 | $1.34 | +273.13% | 1 | Aug 12, 2022 | |
| LMAT LeMaitre Vascular | Maintains: Buy | n/a | $88.06 | - | 2 | Apr 8, 2020 | |
| ANIK Anika Therapeutics | Upgrades: Buy | n/a | $24.56 | - | 1 | Jan 21, 2020 |
Surmodics
May 29, 2024
Downgrades: Neutral
Price Target: $43
Current: $38.83
Upside: +10.74%
STAAR Surgical Company
Nov 7, 2022
Upgrades: Buy
Price Target: n/a
Current: $31.12
Upside: -
Co-Diagnostics
Aug 12, 2022
Downgrades: Neutral
Price Target: $5
Current: $1.34
Upside: +273.13%
LeMaitre Vascular
Apr 8, 2020
Maintains: Buy
Price Target: n/a
Current: $88.06
Upside: -
Anika Therapeutics
Jan 21, 2020
Upgrades: Buy
Price Target: n/a
Current: $24.56
Upside: -